使用β受体阻滞剂控制心率治疗伴有心房颤动的心力衰竭：过犹不及。 - Suppr

Suppr

超能文献

Heart rate control using beta-blockers for heart failure with atrial fibrillation: more than enough is too much.

作者信息

Okumura Takahiro, Kimura Yuki, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Hypertens Res. 2019 Nov;42(11):1826-1827. doi: 10.1038/s41440-019-0303-x. Epub 2019 Jul 30.

DOI:10.1038/s41440-019-0303-x

PMID:31363177

Abstract

摘要

相似文献

Heart rate control using beta-blockers for heart failure with atrial fibrillation: more than enough is too much.使用β受体阻滞剂控制心率治疗伴有心房颤动的心力衰竭：过犹不及。

Hypertens Res. 2019 Nov;42(11):1826-1827. doi: 10.1038/s41440-019-0303-x. Epub 2019 Jul 30.

How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.如何在射血分数降低的心力衰竭合并心房颤动中使用β受体阻滞剂

J Am Coll Cardiol. 2017 Jun 20;69(24):2897-2900. doi: 10.1016/j.jacc.2017.04.049.

Beta-blockers treatment in heart failure with atrial fibrillation--Who should we believe?β受体阻滞剂治疗合并心房颤动的心力衰竭——我们该相信谁？

Int J Cardiol. 2016 Jan 15;203:60-1. doi: 10.1016/j.ijcard.2015.10.096. Epub 2015 Oct 20.

Should β-blockers be used in patients with heart failure and atrial fibrillation?心力衰竭合并心房颤动的患者应该使用β受体阻滞剂吗？

Clin Ther. 2015 Oct 1;37(10):2215-24. doi: 10.1016/j.clinthera.2015.08.017. Epub 2015 Sep 29.

Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.心率决定β受体阻滞剂对心力衰竭合并心房颤动患者心血管结局的有益影响。

Hypertens Res. 2019 Nov;42(11):1716-1725. doi: 10.1038/s41440-019-0289-4. Epub 2019 Jun 18.

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.β 受体阻滞剂在心力衰竭合并心房颤动患者中的疗效：一项个体化患者数据分析荟萃分析。

Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2.

The enigma of beta-blockers, atrial fibrillation and heart failure.β受体阻滞剂、心房颤动与心力衰竭之谜

Int J Cardiol. 2018 Dec 15;273:191-192. doi: 10.1016/j.ijcard.2018.09.055. Epub 2018 Sep 15.

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation-a meta-analysis.β 受体阻滞剂治疗慢性心力衰竭合并心房颤动患者的全因死亡率：一项荟萃分析。

BMC Cardiovasc Disord. 2019 Jun 3;19(1):135. doi: 10.1186/s12872-019-1079-2.

Being cast into the shade of β blockers for concomitant heart failure and atrial fibrillation?在伴有心力衰竭和心房颤动的情况下被β受体阻滞剂掩盖（病情）？

Int J Cardiol. 2015 Jun 1;188:35. doi: 10.1016/j.ijcard.2015.03.431. Epub 2015 Apr 1.

Digoxin and beta-blockers in patients with heart failure. Letter regarding the article 'Clinical outcomes with digoxin vs. beta-blocker for heart rate control in permanent atrial fibrillation with heart failure'.心力衰竭患者中的地高辛和β受体阻滞剂。关于文章“地高辛与β受体阻滞剂对心力衰竭合并永久性心房颤动心率控制的临床结局”的信函

Eur J Heart Fail. 2022 Jan;24(1):239. doi: 10.1002/ejhf.2392. Epub 2021 Dec 5.

引用本文的文献

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.心力衰竭合并心房颤动患者的β受体阻滞剂治疗：挑战与展望。

J Geriatr Cardiol. 2021 May 28;18(5):362-375. doi: 10.11909/j.issn.1671-5411.2021.05.008.

Heart rate fluctuation predicts mortality in critically ill patients in the intensive care unit: a retrospective cohort study.心率波动可预测重症监护病房危重症患者的死亡率：一项回顾性队列研究。

Ann Transl Med. 2021 Feb;9(4):334. doi: 10.21037/atm-20-7897.

本文引用的文献

Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure　- A Nationwide Cohort Study.伴有心力衰竭的心房颤动患者的心率控制治疗结局——一项全国性队列研究。

Circ J. 2018 Feb 23;82(3):652-658. doi: 10.1253/circj.CJ-17-0669. Epub 2017 Nov 14.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。

Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.

Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2.

Is heart rate important for patients with heart failure in atrial fibrillation?心率对于房颤合并心力衰竭患者重要吗？

JACC Heart Fail. 2014 Jun;2(3):213-20. doi: 10.1016/j.jchf.2014.01.005. Epub 2014 Apr 30.

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.心率作为慢性心力衰竭的危险因素（SHIFT）：一项随机安慰剂对照试验中心率与结局的关系。

Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7.

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.荟萃分析：β受体阻滞剂剂量、心率降低与心力衰竭患者的死亡情况

Ann Intern Med. 2009 Jun 2;150(11):784-94. doi: 10.7326/0003-4819-150-11-200906020-00006.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.心房颤动风险评分的开发（弗雷明汉心脏研究）：一项基于社区的队列研究。

Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.沙塔克讲座——千禧之交的心血管医学：成就、担忧与机遇

N Engl J Med. 1997 Nov 6;337(19):1360-9. doi: 10.1056/NEJM199711063371906.

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.卡维地洛可使慢性心力衰竭患者的左心室功能和生存率出现与剂量相关的改善。MOCHA研究组。

Circulation. 1996 Dec 1;94(11):2807-16. doi: 10.1161/01.cir.94.11.2807.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验